LON:SBTX - Skinbiotherapeutics Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Skinbiotherapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 11 +0.50 (+4.76 %) (As of 02/21/2020 04:00 PM ET) Add Compare Today's Range 10.55Now: GBX 11▼ 11.3050-Day Range 10.50MA: GBX 12.87▼ 1552-Week Range 11.30Now: GBX 11▼ 26Volume145,678 shsAverage Volume261,826 shsMarket Capitalization£14.09 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd. SkinBioTherapeutics plc was founded in 2016 and is based in Macclesfield, the United Kingdom. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:SBTX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.skinbiotherapeutics.com/ Phone+44-161-4682760Debt Debt-to-Equity RatioN/A Current Ratio29.49 Quick Ratio28.11Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 2.16 per share Price / Cash Flow5.10 Book ValueGBX 3 per share Price / Book3.67Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees6 Outstanding Shares128,083,000Market Cap£14.09 million Next Earnings DateN/A OptionableNot Optionable Receive SBTX News and Ratings via Email Sign-up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. LSE:SBTX Rates by TradingView Skinbiotherapeutics (LON:SBTX) Frequently Asked Questions What is Skinbiotherapeutics' stock symbol? Skinbiotherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX." How were Skinbiotherapeutics' earnings last quarter? Skinbiotherapeutics PLC (LON:SBTX) posted its quarterly earnings results on Tuesday, November, 26th. The company reported ($0.94) EPS for the quarter. View Skinbiotherapeutics' Earnings History. Has Skinbiotherapeutics been receiving favorable news coverage? News articles about SBTX stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Skinbiotherapeutics earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Skinbiotherapeutics. Who are some of Skinbiotherapeutics' key competitors? Some companies that are related to Skinbiotherapeutics include OptiBiotix Health (OPTI), Asterias Biotherapeutics (AST), Race Oncology (RAC), Zelda Therapeutics (ZLD), Protalix Biotherapeutics (PLX), Tiziana Life Sciences (TILS), ReNeuron Group (RENE), 4d Pharma (DDDD), Immunoprecise Antibodies (IPA), Emerald Health Therapeutics (EMH), Actinium Pharmaceuticals (ATNM), Actinium Pharmaceuticals (ATNM), Covalon Technologies (COV), Armata Pharmaceuticals (ARMP) and Noxopharm (NOX). What other stocks do shareholders of Skinbiotherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Skinbiotherapeutics investors own include Anglo Pacific Group (APF), Avacta Group (AVCT), Inspired Energy (INSE), OptiBiotix Health (OPTI), LB-Shell (LBP), Namibian Resources (AAOG), Big Sofa Technologies Group (BST), Concepta (CPT), Fresnillo (FRES) and Shield Therapeutics (STX). Who are Skinbiotherapeutics' key executives? Skinbiotherapeutics' management team includes the folowing people: Dr. Catherine O'Neill, CEO, Chief Scientific Officer & DirectorMr. Douglas John Quinn, CFO, Company Sec. & DirectorMr. Stuart John Ashman, Exec. Director (Age 52) How do I buy shares of Skinbiotherapeutics? Shares of SBTX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Skinbiotherapeutics' stock price today? One share of SBTX stock can currently be purchased for approximately GBX 11. How big of a company is Skinbiotherapeutics? Skinbiotherapeutics has a market capitalization of £14.09 million. Skinbiotherapeutics employs 6 workers across the globe.View Additional Information About Skinbiotherapeutics. What is Skinbiotherapeutics' official website? The official website for Skinbiotherapeutics is http://www.skinbiotherapeutics.com/. How can I contact Skinbiotherapeutics? Skinbiotherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The company can be reached via phone at +44-161-4682760. MarketBeat Community Rating for Skinbiotherapeutics (LON SBTX)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 46 (Vote Outperform)Underperform Votes: 62 (Vote Underperform)Total Votes: 108MarketBeat's community ratings are surveys of what our community members think about Skinbiotherapeutics and other stocks. Vote "Outperform" if you believe SBTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBTX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: Cost of Goods Sold (COGS)
